The Lancet Commission's report on dementia prevention emphasizes the central role of prevention strategies and adds two new risk factors to the 12 already identified: Visual impairment and high cholesterol. The message is clear: prevention is possible, and by taking action we can significantly reduce the risk of dementia.
Cognoscopy combines laboratory examinations and cognitive tests for the early detection of Alzheimer's disease. With these examinations, you can proactively minimize your risk factors and maintain your quality of life into old age.
The edible mushroom Hericium erinaceus is increasingly becoming the focus of dementia research. Thanks to its bioactive substances such as hericenone and erinacine, the mushroom exhibits a variety of neuroprotective properties. These have already been proven in clinical studies with Alzheimer's patients, where they led to an improvement in cognitive abilities.
α -Lipoic acid is a short-chain fatty acid that can be produced by the body itself as well as absorbed through food and dietary supplements. In addition to its role as a pro-energetic and antioxidant, it has a number of other positive effects in the body and, according to numerous studies, can counteract the progression of dementia diseases such as Alzheimer's.
Studies show a link between chronic stress and the risk of developing Alzheimer's disease. A breathing technique could help reduce this risk by reducing stress and inducing changes in the brain that are associated with biomarkers for Alzheimer's disease.
At regular intervals, we would like to draw your attention to current articles from the Internet that are closely related to our core topic of lifestyle-oriented and self-responsible prevention and treatment of dementia and their relevance. The opinions expressed in the above articles are intended to serve as a stimulus for critical debate. They do not necessarily correspond to the positions we represent, but in all cases they enrich the basis for discussion. At the end of each press article we refer to our scientifically based KsD articles - please take a look for yourself!
The cold shock protein RBM3, which is increasingly produced in the cold, has shown neuroprotective properties in numerous cell culture and animal experiments. A study on mice by the University of Cambridge has now confirmed that RBM3 contributes to the protection of synapses and nerve cells. These findings could be of particular interest for dementia research and other neurodegenerative diseases.
A new animal model sheds light on the dark mystery of Alzeheim disease. A molecule called MEG 3 is capable of causing human brain cells to die, making it a potential risk factor for Alzeheimer's disease.
D-tagatose, a comparatively lesser-known simple sugar, has been shown to lower blood sugar, particularly in studies of diabetics. Given the link between diabetes and dementia, this sugar could be used as a brain-friendly alternative to conventional industrial sugars.
An Australian study found that antibody drugs for Alzheimer's, such as aducanumab and lecanemab, can reduce brain volumes. Despite successful reduction of Alzheimer's-specific amyloid-beta deposits, the benefit of these drugs remains questionable. They slow cognitive decline only slightly and have severe side effects. The study also suggests that these drugs promote the cardinal structural symptom of Alzheimer's disease, brain atrophy. Thus, they increase the risk of brain tissue loss, a direct cause of cognitive decline in Alzheimer's disease.
© Copyright by Deutsche Stiftung für Gesundheitsinformation und Prävention | All Rights Reserved
